The Use of a Pre-operative Carbohydrate Drink in Patients with Diabetes Mellitus: A Prospective, Non-inferiority, Cohort Study

被引:28
作者
Laffin, Michael R. [1 ]
Li, Shuai [2 ]
Brisebois, Rondald [1 ]
Senior, Peter A. [3 ]
Wang, Haili [1 ]
机构
[1] Univ Alberta, Dept Surg, Walter C Mackenzie Hlth Sci Ctr, 2D,8440-112 St, Edmonton, AB T6G 2R3, Canada
[2] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada
[3] Univ Alberta, Div Endocrinol, Edmonton, AB, Canada
关键词
NONCARDIAC SURGERY; ELECTIVE SURGERY; GLYCEMIC CONTROL; METAANALYSIS; OUTCOMES; RISK;
D O I
10.1007/s00268-017-4413-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Pre-operative fasting leads to insulin resistance and increased metabolic stress in non-diabetic patients. Consumption of a carbohydrate drink may alleviate these deleterious effects. Patients with diabetes mellitus represent over 15% of the surgical population, yet concerns over hyperglycemia and aspiration have excluded patients with diabetes mellitus from studies assessing the utility of pre-operative carbohydrate drinks. To assess for a clinically significant increase in pre-operative blood glucose concentration (defined as > 2 mmol/L) in patients with diabetes consuming a pre-operative carbohydrate drink. A prospective observational non-inferiority cohort study of 106 subjects with diabetes mellitus was undertaken to assess the effect of consuming a pre-operative carbohydrate drink in surgical patients. All patients with diabetes mellitus undergoing surgery (including but not limited to cardiac, neurologic, urologic, and general surgical procedures) were enrolled. Subjects were instructed to consume two carbohydrate-rich drinks, one before sleeping the evening prior to surgery and another on the day of surgery. In total, 43% of subjects were fully compliant with the pre-operative carbohydrate drink regimen. There were no significant differences between the fully compliant and non-compliant subjects with respect to baseline characteristics. Consumption of a pre-operative carbohydrate drink was determined to be non-inferior to fasting in terms of pre-operative blood glucose concentration (absolute difference 0.23 mmol/L, 95% CI: -1.00 to 1.45 mmol/L, p (non-inferiority) < 0.01). Neither group was found to be superior in terms of pre-operative blood glucose concentration, hyperglycemia, or length of stay. These findings function as a step toward ensuring pre-operative carbohydrate drinks are safe in patients with diabetes undergoing surgery.
引用
收藏
页码:1965 / 1970
页数:6
相关论文
共 50 条
  • [41] Relationship Between Long-Term Objectively Measured Physical Activity and Glycemic Control in Type 2 Diabetes Mellitus Patients: A Prospective Cohort Study
    Masuda, Hiroaki
    Ishiyama, Daisuke
    Yamada, Minoru
    Iwashima, Fumiko
    Kimura, Yosuke
    Otobe, Yuhei
    Tani, Naoki
    Suzuki, Mizue
    Nakajima, Hideki
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 2057 - 2063
  • [42] Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study
    Alex Z Fu
    Ying Qiu
    Larry Radican
    Donald D Yin
    Panagiotis Mavros
    Cardiovascular Diabetology, 9
  • [43] PRE-Operative ECHOcardiograhy for prevention of cardiovascular events after non-cardiac surgery in intermediate- and high-risk patients: protocol for a low-interventional, mixed-cohort prospective study design (PREOP-ECHO)
    Kim, Eun Kyoung
    Choi, Hong-Mi
    Choi, Eui-Young
    Lee, Hye Sun
    Park, Goeun
    Han, Dong Woo
    Lee, Sang-Eun
    Park, Chan Seok
    Hwang, Ji-won
    Choi, Jae Hyuk
    Kim, Mi-Na
    Kim, Hyung-Kwan
    Kim, Dae-Hee
    Shin, Sung-Hee
    Sohn, Il Suk
    Shin, Mi-Seung
    Na, Jin Oh
    Cho, Iksung
    Lee, Sun Hwa
    Park, Yong Hyun
    Park, Tae-Ho
    Kim, Kye Hun
    Cho, Goo-Young
    Jung, Hae Ok
    Park, Dae-Gyun
    Hong, Ji Yeon
    Kang, Duk-Hyun
    TRIALS, 2022, 23 (01)
  • [44] PRE-OPerative ECHOcardiograhy for prevention of cardiovascular events after non-cardiac surgery in intermediate- and high-risk patients: protocol for a low-interventional, mixed-cohort prospective study design (PREOP-ECHO)
    Eun Kyoung Kim
    Hong-Mi Choi
    Eui-Young Choi
    Hye Sun Lee
    Goeun Park
    Dong Woo Han
    Sang-Eun Lee
    Chan Seok Park
    Ji-won Hwang
    Jae Hyuk Choi
    Mi-Na Kim
    Hyung-Kwan Kim
    Dae-Hee Kim
    Sung-Hee Shin
    Il Suk Sohn
    Mi-Seung Shin
    Jin Oh Na
    Iksung Cho
    Sun Hwa Lee
    Yong Hyun Park
    Tae-Ho Park
    Kye Hun Kim
    Goo-Young Cho
    Hae Ok Jung
    Dae-Gyun Park
    Ji Yeon Hong
    Duk-Hyun Kang
    Trials, 23
  • [45] Trimethylamine N-oxide predicts cardiovascular events in coronary artery disease patients with diabetes mellitus: a prospective cohort study
    Yu, Xue
    Wang, Yijia
    Yang, Ruiyue
    Wang, Zhe
    Wang, Xinyue
    Wang, Siming
    Zhang, Wenduo
    Dong, Jun
    Chen, Wenxiang
    Ji, Fusui
    Gao, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [46] Effi cacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial
    Pasquel, Francisco J.
    Gianchandani, Roma
    Rubin, Daniel J.
    Dungan, Kathleen M.
    Anzola, Isabel
    Gomez, Patricia C.
    Peng, Limin
    Hodish, Israel
    Bodnar, Tim
    Wesorick, David
    Balakrishnan, Vijay
    Osei, Kwame
    Umpierrez, Guillermo E.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (02) : 125 - 133
  • [47] Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: A retrospective cohort study
    Hwang, Eu Chang
    Kim, Young Jung
    Hwang, In Sang
    Hwang, Jun Eul
    Jung, Seung Il
    Kwon, Dong Deuk
    Park, Kwangsung
    Ryu, Soo Bang
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (11) : 769 - 776
  • [48] Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study
    Ichikawa, Keishi
    Miyoshi, Toru
    Osawa, Kazuhiro
    Miki, Takashi
    Toda, Hironobu
    Ejiri, Kentaro
    Yoshida, Masatoki
    Nanba, Yusuke
    Yoshida, Masashi
    Nakamura, Kazufumi
    Morita, Hiroshi
    Ito, Hiroshi
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [49] Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China
    Zhu, Yue
    Forsman, Lina Davies
    Chen, Cheng
    Zhang, Haoyue
    Shao, Ge
    Wang, Sainan
    Wang, Shanshan
    Xiong, Haiyan
    Bruchfeld, Judith
    Wang, Weibing
    Zhu, Limei
    Alffenaar, Jan-Willem
    Hu, Yi
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (02) : 524 - 533
  • [50] Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study
    Zhang, Yan
    Jin, Jing-Lu
    Cao, Ye-Xuan
    Zhang, Hui-Wen
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Zhu, Cheng-Gang
    Gao, Ying
    Hua, Qi
    Li, Yan-Fang
    Xu, Rui-Xia
    Li, Jian-Jun
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)